![](/img/cover-not-exists.png)
Effective gmp-compliant point of care manufacturing of anticd19 chimeric antigen receptor t cells for non hodgkin lymphoma patients using the clinimacs prodigy®
Kleinsorge-Block, S., Payne-Schiavone, J., Zamborsky, K., Turney, T.L., Reese, J., Wald, D., Otegbeye, F., de Lima, M., Caimi, P.F.Volume:
22
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2020.03.261
Date:
May, 2020
File:
PDF, 157 KB
2020